HHS Should Track All Rx Clinical Trials, AMA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
All trials should be registered to ensure results are publicly available, physicians’ association says. Institutional review boards should not approve trials unless they are registered, AMA policy urges.
You may also be interested in...
Clinical Trial Sponsors Urged To Post Study Design Details Ahead Of Results
Vermont Assistant Attorney General Brill says disclosure of clinical trial results on a central registry and posting of a study's design and endpoints before the results would suggest "true disclosure," not off-label marketing.
Clinical Trial Sponsors Urged To Post Study Design Details Ahead Of Results
Vermont Assistant Attorney General Brill says disclosure of clinical trial results on a central registry and posting of a study's design and endpoints before the results would suggest "true disclosure," not off-label marketing.
Trial Registries Would Boost Public Trust In Clinical Studies – Survey
Two-thirds of Americans queried in a December 2004 survey believe clinical trials are safe for participants, the Center for Information & Study on Clinical Research Participation reports. More than half of respondents said a public database of clinical trial results would boost their trust in such studies.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: